| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 35 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $60.29M | - | |
| COO | 63.4K | $28.62M | - | |
| VP | 51.1K | $23.07M | - | |
| VP | 42.3K | $19.10M | - | |
| Other | 24.0K | $10.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 18, 2023 | Lee Yuchun | Director | Sale+OE | 4,442 | $312.04 | $1,386,099.14 | -54.2% | +4.9% | +39.7% | |
| Nov 15, 2022 | Altshuler David48 | EVP, Global Research And CSO | Sell | 34 | $308.61 | $10,492.74 | - | -2.0% | +14.4% | |
| Nov 7, 2022 | Altshuler David48 | EVP, Global Research And CSO | Sale+OE | 1,303 | $303.04 | $394,858.63 | -0.5% | +0.5% | +24.7% | |
| Nov 2, 2022 | Sanna Bastiano | EVP, Cell &Genetic Therapies | Sell | 320 | $312.64 | $100,045.10 | -0.1% | +4.2% | +21.5% | |
| Oct 24, 2022 | Bhatia Sangeeta N.48 | Director | Sell | 621 | $310.00 | $192,510.00 | -13.3% | +0.4% | +19.0% | |
| Oct 18, 2022 | Sanna Bastiano | EVP, Cell &Genetic Therapies | Sell | 1,791 | $300.31 | $537,859.98 | -2.2% | +3.9% | +22.4% | |
| Aug 15, 2022 | Kewalramani Reshma55 | CEO &President | Sell | 11,689 | $305.06 | $3,565,846.34 | -10.5% | +0.2% | +14.5% | |
| Aug 15, 2022 | Arbuckle Stuart A | EVP, COO | Sale+OE | 22,173 | $303.93 | $6,738,990.78 | -6.0% | +0.2% | +14.5% | |
| Aug 15, 2022 | Liu Joy | SVP, General Counsel | Sell | 3,747 | $303.90 | $1,138,722.73 | -5.1% | +0.2% | +14.5% | |
| Aug 10, 2022 | Arbuckle Stuart A | EVP, COO | Sale+OE | 180 | $300.40 | $54,072.81 | -0.1% | +3.6% | +17.4% |